We spoke with hundreds of doctors, scientists and, patients at #ACOG2022. We even seized the opportunity to talk with CBS 8 San Diego about protecting women’s reproductive health. Safety Info: Don't use if you have 3+ UTIs per year. see bit.ly/3kTpij9 for PI and more risks.

US Food and Drug Administration Extends Phexxi® Shelf Life to Four Years. $EVFM prn.to/3PPQPjX

Dr. Bassem Maximos shares insights from new research on our product. Read more at the link below. pharmashots.com/7775/pharmasho…

Evofem Partners with a360 Media to Support Phexxi® Prescription Growth $EVFM prn.to/3olEDL2

Evofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act $EVFM prn.to/3PNiXDi

After the House vote on the Right to Contraception Act, Saundra Pelletier says, “if we aren’t fierce about this…we’re going to actually create implications for half of our population that are going to be dire.” Thanks to Nicole DeFeudis & Endpoints News. bit.ly/3zrE0WN

Love starting the week with fabulous positive feedback about Evofem Biosciences’s Phexxi from HCPs at ISSWSH annual meeting last weekend! #sexualhealth $EVFM

EVFM negotiates 7.4% improved rebate for Phexxi with Medi-Cal with > 15.4 M covered lives. #contraception, $EVFM, #Phexxi evofem.investorroom.com/2024-03-20-Evo…

👍🏻 USA TODAY raising awareness that women using #GLP -1s who take oral #BirthControl pills should use a non-systemic, non-hormonal method to provide supplemental protection against unintended pregnancy at certain points in dosing schedule #WomensHealth #contraception Evofem Biosciences

This insightful CNN article sheds light on why GLP-1s may render birth control pills less effective. Women who use these drugs concomitantly can add a hormone-free, on-demand method like [#rhymeswithsexy] for supplemental protection against unintended pregnancy.

MarketGems #Podcast Ep. 3 with Evofem Biosciences, Inc.'s Amy Raskopf is Now LIVE! Tune In Now 👉 youtube.com/watch?v=pUoww_… $EVFM #OTCQB #Womenshealth #Hormonefree #Contraception #StockstoWatch #Investing

New US patent issued covering Phexxi’s composition and methods for #contraception. Learn more at evofem.investorroom.com/2024-06-11-Evo…. Evofem Biosciences $EVFM #hormonefree #birthcontrol #womenhealth #IP

Thank you Bernie Sanders and The New York Times for raising awareness of the tactics still used by some insurance companies to avoid covering birth control as they are mandated to do under the ACA #affordablecareact #ACA #contraception #birthcontrol #WomensHealth nytimes.com/2024/06/26/wel…

Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC Evofem Biosciences $EVFM #womenshealth #BV #trichomoniasis #STD prnewswire.com/news-releases/…

ICYMI Aditxt, Inc. and women's health innovator Evofem Biosciences have amended and restated their Merger Agreement, are targeting Sept. 30 closing $ADTX $EVFM finance.yahoo.com/news/aditxt-ev…

Evofem Biosciences & Aditxt, Inc. subsidiary Pearsanta forge collaboration for targeted launch of endometriosis diagnostic; chronic condition affects 1 in 10 women. $EVFM $ADTX #womenshealth #endometriosis #diagnostic businesswire.com/news/home/2024…

🌟 Join me on October 28th at 11:30 AM ET for a chat with @aditXt CEO Amro Albanna & Dr. Drew📺🎙️! We’ll share updates and answer your questions in a live Q&A. Submit your Qs by Oct 25! Register here: lnkd.in/g8RfryVa #WomensHealth #Biotech #ReproductiveHealth #Healthcare

🎤📹 Just wrapped an inspiring virtual discussion with Amro Albanna of Aditxt and Dr. Drew! Honored to connect with leaders who are as passionate about health and innovation as we are. Can’t wait to share more of what’s in store in the coming weeks—stay tuned! #ReproductiveHealth

🎉 New Year, New Conversations! ✨ 🎧 Lisen now: open.spotify.com/episode/7cW1kf… As we step into 2025, I couldn’t be more thrilled to share my appearance on the Love Mia Vita Podcast with the inspiring Gerianne DiPiano. ‘Love Mia Vita’ means ‘Love My Life,’ and it’s a mantra we should

Evofem Biosciences Reports Fourth Consecutive Year of Net Sales Growth bit.ly/41TzTQl -- Net sales increased 6% to $19.4M in 2024; OpEx decreased 27%; $EVFM entered into Fifth Amendment to A&R Merger Agreement with Aditxt, Inc. $ADTX #womenshealth #EarningsReports